NCT02938026

Brief Summary

Nutrition therapy is recognized as one of the crucial components for the standard treatment of diabetes along with physical activity and drug therapy. Of note, dietary habits are culture specific and hence understanding the dietary intake, eating behavior and physical activity level of the local population is important to formulate effective nutrition and lifestyle strategies. Weight control is a major therapeutic challenge because many conventionally used anti-diabetic agents, such as sulphonylurea and insulin, can cause weight gain, thus setting up a vicious cycle with increasing insulin resistance due to increasing levels of free fatty acids from adipose tissues . Although intensive face-to-face lifestyle intervention program has showed that even modest weight loss in people with Type 2 diabetes (T2DM) who were overweight or obese was associated with improvements in glycemic control and associated conditions, it may not be feasible in public hospital setting in Hong Kong due to factors such as limited resources, scheduling, patient's employment and willingness for frequent travel to the clinic. Hence, alternative strategies such as a combination of face- to-face individual dietary and lifestyle consultation together with telephone intensive lifestyle reinforcement program will likely to be an useful strategy to engage those obese T2DM patients through frequent individual contacts. On the other hand, bariatric surgery has emerged as an impressive therapeutic option for poorly control obese T2DM patients. Realizing there is a knowledge gap in understanding the lifestyle factors in the Hong Kong Chinese obese T2DM patients, we therefore propose to conduct a 1-year prospective clinical trial with two main objectives:

  1. 1.To study and compare the glycemic and weight improvement after bariatric surgery versus a telephone intensive lifestyle intervention program for 1 year in Hong Kong Chinese obese patients with type 2 diabetes.
  2. 2.To investigate the effect of lifestyle factors including dietary intake, eating behaviors and physical activity level on the glycemic and weight control of Hong Kong Chinese obese patients with type 2 diabetes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
141

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 17, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 19, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

July 24, 2018

Status Verified

July 1, 2018

Enrollment Period

1.8 years

First QC Date

October 17, 2016

Last Update Submit

July 21, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of HbA1c

    1 year

  • Change of weight

    1 year

Study Arms (3)

Control

NO INTERVENTION

Usual care

Telephone intensive lifestyle counseling

EXPERIMENTAL

Telephone intensive lifestyle counseling

Behavioral: Telephone Intensive Lifestyle Counselling

Bariatric surgery

EXPERIMENTAL

Bariatric surgery

Procedure: Bariatric surgery

Interventions

Bariatric surgery
Telephone intensive lifestyle counseling

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 - 65 years
  • Chinese ethnicity
  • BMI ≥27.5 kg/m2
  • Diagnosis of T2DM
  • No active cardiovascular diseases
  • ASA grade II or below (for the bariatric surgery group)
  • Able to read Chinese and give informed written consent

You may not qualify if:

  • Type 1 diabetes mellitus
  • End-stage renal failure requiring dialysis or chronic kidney disease (CKD) stage 4 or above
  • Malignancy diagnosed within 3 years
  • Major psychiatric illness
  • Pregnancy or lactation
  • Significant anaesthetic risk ASA grade III or above (for the bariatric surgery group)
  • Any medical illness or condition as judged by the investigators as ineligible to participate the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Bariatric Surgery

Intervention Hierarchy (Ancestors)

BariatricsObesity ManagementTherapeuticsSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student in medical science

Study Record Dates

First Submitted

October 17, 2016

First Posted

October 19, 2016

Study Start

May 1, 2016

Primary Completion

March 1, 2018

Study Completion

March 1, 2018

Last Updated

July 24, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share